Search research articles
Contact Us
Filters
Showing results (301-310 of 385) with videos related to
Page
of 39
Sort By:
BMC Psychiatry
|
May 10, 2023
Impact of COVID-19 on electroconvulsive therapy practice across Canadian provinces during the first wave of the pandemic
Ilya Demchenko, Vanessa K Tassone, Sarah Dunnett, et al.
The Journal of ECT
|
June 25, 2025
Evolution of Electroconvulsive Therapy Practice During the COVID-19 Pandemic: A Systematic Review
Josh Martin, Argyrios Perivolaris, Nadeen M Tantash, et al.
Kidney International Reports
|
October 11, 2022
Genomic Study on Blood Culture Isolates From Patients With <i>Staphylococcus</i> Infection-associated Glomerulonephritis
Pranav S J B Rana, Jihad Aljabban, Melanie Prarat, et al.
Psychological Medicine
|
August 25, 2022
Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report
Mehri Sajjadian, Rudolf Uher, Keith Ho, et al.
Journal of Cardiac Failure
|
May 2, 2024
Sex-Based Differences in the Epidemiology, Clinical Characteristics, and Outcomes Associated with Worsening Heart Failure Events in a Learning Health System
Chloe J Leung, Ankeet S Bhatt, Alan S Go, et al.
Focus (American Psychiatric Publishing)
|
September 6, 2021
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression
Brent P Forester, Sagar V Parikh, Sara Weisenbach, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
June 10, 2020
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression
Brent P Forester, Sagar V Parikh, Sara Weisenbach, et al.
Journal of Psychiatric Research
|
January 25, 2019
Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
John F Greden, Sagar V Parikh, Anthony J Rothschild, et al.
BMC Medical Genetics
|
January 7, 2014
Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1
Wei Xu, Sarah Cohen-Woods, Qian Chen, et al.
Kidney International
|
July 5, 2022
Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis
Samir V Parikh, Ana Malvar, Huijuan Song, et al.
Page
of 39
Search research articles
Search
Showing results (301-310 of 385) with videos related to
Sort By:
Page
of 39
BMC Psychiatry
|
May 10, 2023
Impact of COVID-19 on electroconvulsive therapy practice across Canadian provinces during the first wave of the pandemic
Ilya Demchenko, Vanessa K Tassone, Sarah Dunnett, et al.
The Journal of ECT
|
June 25, 2025
Evolution of Electroconvulsive Therapy Practice During the COVID-19 Pandemic: A Systematic Review
Josh Martin, Argyrios Perivolaris, Nadeen M Tantash, et al.
Kidney International Reports
|
October 11, 2022
Genomic Study on Blood Culture Isolates From Patients With <i>Staphylococcus</i> Infection-associated Glomerulonephritis
Pranav S J B Rana, Jihad Aljabban, Melanie Prarat, et al.
Psychological Medicine
|
August 25, 2022
Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report
Mehri Sajjadian, Rudolf Uher, Keith Ho, et al.
Journal of Cardiac Failure
|
May 2, 2024
Sex-Based Differences in the Epidemiology, Clinical Characteristics, and Outcomes Associated with Worsening Heart Failure Events in a Learning Health System
Chloe J Leung, Ankeet S Bhatt, Alan S Go, et al.
Focus (American Psychiatric Publishing)
|
September 6, 2021
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression
Brent P Forester, Sagar V Parikh, Sara Weisenbach, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
June 10, 2020
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression
Brent P Forester, Sagar V Parikh, Sara Weisenbach, et al.
Journal of Psychiatric Research
|
January 25, 2019
Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
John F Greden, Sagar V Parikh, Anthony J Rothschild, et al.
BMC Medical Genetics
|
January 7, 2014
Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1
Wei Xu, Sarah Cohen-Woods, Qian Chen, et al.
Kidney International
|
July 5, 2022
Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis
Samir V Parikh, Ana Malvar, Huijuan Song, et al.
Page
of 39